Compare Train & 3D-4D Left Ventricular Systolic Function in Subjects

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Steinert's disease is an orphan disease. The prognosis of patients with this disease is conditioned by cardiac involvement. Search an early stage alterations in contractile function in subjects suffering from dystrophy would detect patients at risk of sudden death. The first stage of work is to validate the tools to detect early stage of infringement systolic function in a population of patients with myotonic dystrophy.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00082108` - Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Not yet recruiting	`NCT05532813` - Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)	Phase 3
Recruiting	`NCT02398786` - Myotonic Dystrophy Family Registry

NCT number	NCT02930408
Study type	Interventional
Source	Poitiers University Hospital
Contact
Status	Terminated
Phase	N/A
Start date	January 2014

Compare Train and 3D-4D Left Ventricular Systolic Function in Subjects Suffering From Dystrophy and Healthy Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms